@Article{,
AUTHOR = {Sam D. Graham, Jr., Mary Elizabeth Warden, Jeffrey Lou},
TITLE = {Molecular targeted therapies for renal cell carcinoma},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {14},
YEAR = {2007},
NUMBER = {Suppl.6},
PAGES = {48--52},
URL = {http://www.techscience.com/CJU/v14nSuppl.6/63320},
ISSN = {1488-5581},
ABSTRACT = {New advances in technology to directly target specific
molecular events in the proliferation of cancer have led to
promising results in renal cell carcinoma. Response rates
in excess of 70% and complete responses in advanced
(metastatic) renal cell carcinoma have caused a change in
the paradigm of treatment from immunotherapy. Toxicities
are significant, but manageable and pushing the toxicity to
tolerability may increase the response rate.},
DOI = {}
}